Effect of nipradilol on aqueous flow in glaucoma patients treated with timolol

Journal of Japanese Ophthalmological Society

Volumn 101, Issue 3, 1997, Pages 252-256

  Nagataki, Shigetoshi ^a,d   Koseki, Yoshiyuki ^a   Yamakawa, Ryoji ^b   Koibuchi, Hiroshi ^c  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

^b TENRI HOSPITAL   (Japan)

^c JR Tokyo General Hospital   (Japan)

^d NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

Aqueous flow; Nipradilol; Open angle glaucoma; Timolol

Indexed keywords

NIPRADILOL; PLACEBO; TIMOLOL;

ADULT; AGED; AQUEOUS HUMOR FLOW; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG MIXTURE; FEMALE; FLUOROPHOTOMETRY; HUMAN; INTRAOCULAR HYPERTENSION; MALE; OPEN ANGLE GLAUCOMA; RANDOMIZED CONTROLLED TRIAL; TOPICAL DRUG ADMINISTRATION;

ADRENERGIC ALPHA-ANTAGONISTS; ADRENERGIC BETA-ANTAGONISTS; AQUEOUS HUMOR; FEMALE; GLAUCOMA; GLAUCOMA, OPEN-ANGLE; HUMANS; MALE; MIDDLE AGED; PROPANOLAMINES; TIMOLOL;

EID: 0030964468     PISSN: 00290203     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. 2 adrenergic binding sites in bovine retina and retinal blood vessels. Invest Ophthalmol Vis Sci 29: 695-699, 1988.
2. Martin XD, Rabineau PA: Vasoconstrictive effect of topical timolol on human retinal arteries. Graefes Arch Clin Exp Ophthalmol 227 : 526-530, 1989.
3. Van Buskirk EM, Bacon DR, Fahrenbach WH: Ciliary vasoconstriction after topical adrenergic drugs. Am J Ophthalmol 109: 511-517, 1990.
4. Nelson WJ, Fraunfelder FT, Sills JM, Arrowsmith JB, Kuritsky JN : Adverse respiratory and cardiovascular events attributed to timolol ophthalmic solution, 1978-1985. Am J Ophthalmol 102: 606-611, 1986.
5. Stewart RH, Kimbrough RL, Ward RL: Betaxolol and timolol a six-month double-blind comparison. Arch Ophthalmol 104: 46-48, 1986.
6. Brubaker RF : Clinical evaluation of the circulation of aqueous humor. In : Tasman W, et al (Eds): Duane's Clinical Ophthalmology. Vol 3. Chapter 46, JB Lippincott, Philadelphia, 1994.
7. Mori M, Araie M: Effect of apraclonidine on blood-aqueous barrier permeability to plasma protein in man. Exp Eye Res 54: 555-559, 1992.
8. Coakes RL, Brubaker RF: The mechanism of timolol in lowering intraocular pressure. Arch Ophthalmol 96: 2045-2048, 1978.
9. Dailey RA, Brubaker RF, Bourne WM : The effects of timolol maleate and acetazolamide on the rate of aqueous formation in normal human subjects. Am J Ophthalmol 93: 232-237, 1982.
10. Gharagozloo NZ, Reif SJ, Brubaker RF : Aqueous flow is reduced by the alpha-adrenergic agonist, apraclonidine hydrochloride (ALO 2145). Ophthalmology 95: 1217-1220, 1988.
11. Koskela T, Brubaker RF : Apraclonidine and timolol. Combined effects in previously untreated normal subjects. Arch Ophthalmol 109: 804-806, 1991.
12. Gharagozloo NZ, Brubaker RF : Effect of apraclonidine in long-term timolol users. Ophthalmology 98: 1543-1546, 1991.
13. Brubaker RF, Nagataki S, Bourne WM: Effect of chronically administered timolol on aqueous humor flow in patients with glaucoma. Ophthalmology 89: 280-283, 1982.
14. Serle JB, Stein AJ, Podos SM, Severin CH: Corynanthine and aqueous humor dynamics in rabbits and monkeys. Arch Ophthalmol 102: 1385 - 1388, 1984.
15. Schuman JS, Erickson K, Nathanson JA: Nitrovasodilator effects on intraocular pressure and outflow facility in monkeys. Exp Eye Res 58: 99-105, 1994.